Cerebrospinal fluid of an infant with neonatal meningitis, 1978
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Serotype III
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 44: Brain Heart Infusion Agar/Broth
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor
CJ Baker
Special Collection
NCRR Contract
Year of Origin
1978
References
Anderson DC, et al. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr. Res. 17: 496-502, 1983. PubMed: 6348689
Kasper DL, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98: 2308-2314, 1996. PubMed: 8941648
